Effect of Jyotishmati Capsule in the management of Chittodvega Generalized Anxiety Disorder

Comparative evaluation of efficacy Of Jyotishmati capsule versus Ashwagandha capsule in the management of Chittodvega Generalized Anxiety Disorder - A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047596

Enrollment

Registered

2022-11-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be selected according to DSM-V and ICD 10 criteria A score of less than 24 on HAM-A scale Age group of 20 to 50 years of either sex Restlessness or Feeling keyed up easily fatigued Difficulty in concentrating Irritability Muscle tension Sleep disturbance

Exclusion criteria

Exclusion criteria: A score of more than 24 on HAM-A scale GAD associated with other disorders like neurological disorders systemic conditions endocrine disorders deficiency states toxic condition idiopathic psychological disorders Chittodvega due to direct physiological effect of a substance (e.g. a drug abuse, a medication) or a general medical condition (e.g. Hyperthyroidism)

Design outcomes

Primary

Measure	Time frame
Reduction in the score of HAM-A scaleTimepoint: 30 Days	—

Secondary

Measure	Time frame
Improvement in Quality of life scaleTimepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Reeya Gamne

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha

sadhanamisar@gmail.com9763732083

Outcome results